Literature DB >> 21227703

Synthesis and biological activity of optically active NCL-1, a lysine-specific demethylase 1 selective inhibitor.

Daisuke Ogasawara1, Takayoshi Suzuki, Koshiki Mino, Rie Ueda, Mohammed Naseer Ahmed Khan, Takuya Matsubara, Koichi Koseki, Makoto Hasegawa, Ryuzo Sasaki, Hidehiko Nakagawa, Tamio Mizukami, Naoki Miyata.   

Abstract

Optically active (1S,2R)-NCL-1 and (1R,2S)-NCL-1 were synthesized and evaluated for their lysine-specific demethylase 1 inhibitory activity and cell growth inhibitory activity. In enzyme assays, the (1S,2R)-isomer was approximately four times more potent than the (1R,2S)-isomer. In cell growth inhibition assays, the two isomers showed similar activity in HEK293 cells and SH-SY5Y cells, whereas the (1S,2R)-isomer showed approximately four times more potent activity than the (1R,2S)-isomer in HeLa cells.
Copyright © 2010 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 21227703     DOI: 10.1016/j.bmc.2010.12.024

Source DB:  PubMed          Journal:  Bioorg Med Chem        ISSN: 0968-0896            Impact factor:   3.641


  14 in total

Review 1.  Epigenetic protein families: a new frontier for drug discovery.

Authors:  Cheryl H Arrowsmith; Chas Bountra; Paul V Fish; Kevin Lee; Matthieu Schapira
Journal:  Nat Rev Drug Discov       Date:  2012-04-13       Impact factor: 84.694

Review 2.  Small molecule epigenetic inhibitors targeted to histone lysine methyltransferases and demethylases.

Authors:  Zhanxin Wang; Dinshaw J Patel
Journal:  Q Rev Biophys       Date:  2013-09-02       Impact factor: 5.318

3.  Structure-activity study for (bis)ureidopropyl- and (bis)thioureidopropyldiamine LSD1 inhibitors with 3-5-3 and 3-6-3 carbon backbone architectures.

Authors:  Shannon L Nowotarski; Boobalan Pachaiyappan; Steven L Holshouser; Craig J Kutz; Youxuan Li; Yi Huang; Shiv K Sharma; Robert A Casero; Patrick M Woster
Journal:  Bioorg Med Chem       Date:  2015-02-07       Impact factor: 3.641

Review 4.  Epigenetic pathway targets for the treatment of disease: accelerating progress in the development of pharmacological tools: IUPHAR Review 11.

Authors:  David F Tough; Huw D Lewis; Inmaculada Rioja; Matthew J Lindon; Rab K Prinjha
Journal:  Br J Pharmacol       Date:  2014-11       Impact factor: 8.739

5.  Novel KDM1A inhibitors induce differentiation and apoptosis of glioma stem cells via unfolded protein response pathway.

Authors:  G R Sareddy; S Viswanadhapalli; P Surapaneni; T Suzuki; A Brenner; R K Vadlamudi
Journal:  Oncogene       Date:  2016-11-28       Impact factor: 9.867

6.  Low molecular weight amidoximes that act as potent inhibitors of lysine-specific demethylase 1.

Authors:  Stuart Hazeldine; Boobalan Pachaiyappan; Nora Steinbergs; Shannon Nowotarski; Allison S Hanson; Robert A Casero; Patrick M Woster
Journal:  J Med Chem       Date:  2012-09-04       Impact factor: 7.446

Review 7.  Epigenetics: A primer for clinicians.

Authors:  Benjamin E Paluch; Abdul R Naqash; Zachary Brumberger; Michael J Nemeth; Elizabeth A Griffiths
Journal:  Blood Rev       Date:  2016-02-26       Impact factor: 8.250

Review 8.  The Curtius rearrangement: mechanistic insight and recent applications in natural product syntheses.

Authors:  Arun K Ghosh; Anindya Sarkar; Margherita Brindisi
Journal:  Org Biomol Chem       Date:  2018-02-26       Impact factor: 3.876

9.  The KDM1A histone demethylase is a promising new target for the epigenetic therapy of medulloblastoma.

Authors:  Kristian W Pajtler; Christina Weingarten; Theresa Thor; Annette Künkele; Lukas C Heukamp; Reinhard Büttner; Takayoshi Suzuki; Naoki Miyata; Michael Grotzer; Anja Rieb; Annika Sprüssel; Angelika Eggert; Alexander Schramm; Johannes H Schulte
Journal:  Acta Neuropathol Commun       Date:  2013-05-29       Impact factor: 7.801

10.  Synthesis, LSD1 Inhibitory Activity, and LSD1 Binding Model of Optically Pure Lysine-PCPA Conjugates.

Authors:  Yukihiro Itoh; Daisuke Ogasawara; Yosuke Ota; Tamio Mizukami; Takayoshi Suzuki
Journal:  Comput Struct Biotechnol J       Date:  2014-02-15       Impact factor: 7.271

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.